Certain features warrant prompt medical evaluation: Severe muscle pain or weakness , particularly if accompanied by dark urine, which may indicate rhabdomyolysis (a rare but serious condition involving muscle breakdown) Joint swelling, redness, or warmth , which could suggest inflammatory arthritis or infection (septic arthritis) Pain that significantly impairs daily activities or does not respond to simple analgesia Systemic symptoms such as fever, unexplained weight loss (beyond expected therapeutic effect), or night sweats New or worsening pain following dose escalation, which may require dose adjustment or further investigation Sudden, severe pain in the right upper abdomen , possibly with fever or jaundice, which could indicate gallbladder disease (a recognised risk with GLP-1 receptor agonists) [1] [5] Patients should also seek advice if they experience other concerning adverse effects of Ozempic, including: Persistent nausea or vomiting leading to dehydration or reduced fluid intake Symptoms of hypoglycaemia (tremor, sweating, confusion), particularly if taking Ozempic with insulin or sulphonylureas Severe abdominal pain, which may indicate pancreatitis (a known but uncommon risk with GLP-1 receptor agonists) [1] [5] Visual changes or signs of diabetic retinopathy progression For urgent concerns outside of GP hours, patients should contact NHS 111
Food and Drug Administration (FDA) in early June and sold under the brand name Wegovy, is for chronic weight management in clinically obese adults, who are defined as those with a body mass index (BMI) of 30 or greater
This controlled movement assures that the correct dose of insulin is delivered
Armstrong, a pediatrician and medical weight management specialist at Duke Health
Nutrition Vital When Taking GLP-1 Weight Loss Drugs. UCHealth Today, 19 May 2025
Also, p-ERK/t-ERK did not differ between 30 and 60 min of 10 ng/mL LPS treatment (Fig
